Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Ginkgo Bioworks Holdings (NYSE:DNA) through any online brokerage.
Other companies in Ginkgo Bioworks Holdings’s space includes: 10x Genomics Inc (NASDAQ:TXG), Codexis Inc (NASDAQ:CDXS), BioLife Solutions Inc (NASDAQ:BLFS), Lifecore Biomedical Inc (NASDAQ:LFCR) and Quanterix Corp (NASDAQ:QTRX).
Ginkgo Bioworks Holdings has a consensus price target of $4.63.
The stock price for Ginkgo Bioworks Holdings (NYSE: DNA) is $9.02 last updated January 20, 2026 at 6:30 AM EST.
There are no upcoming dividends for Ginkgo Bioworks Holdings.
Ginkgo Bioworks Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Ginkgo Bioworks Holdings.
Ginkgo Bioworks Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.